Tom Gayner Markel Group
Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$12M |
| 2 |
Starbucks
SBUX
|
+$9.08M |
| 3 |
Capital One
COF
|
+$7.47M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$7.33M |
| 5 |
Goldman Sachs
GS
|
+$6.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$46.3M |
| 2 |
Moody's
MCO
|
+$14.6M |
| 3 |
Brown-Forman Class A
BF.A
|
+$11.3M |
| 4 |
Factset
FDS
|
+$9.69M |
| 5 |
PACCAR
PCAR
|
+$8.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.83% |
| 2 | Consumer Discretionary | 18.26% |
| 3 | Industrials | 12.08% |
| 4 | Healthcare | 10.06% |
| 5 | Consumer Staples | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
GE Aerospace
GE
$361B
| $1.28M | 0.02% |
19,823
| – | – |
|
127
ScottsMiracle-Gro
SMG
$3.55B
| $1.11M | 0.02% |
+13,000
| New | +$1.24M |
|
128
Atlanta Braves Holdings Series A
BATRA
$3.64B
| $968K | 0.02% |
42,600
| – | – |
|
129
Hormel Foods
HRL
$13.1B
| $652K | 0.01% |
19,000
| – | – |
|
130
Bristol-Myers Squibb
BMY
$137B
| $632K | 0.01% |
10,000
| – | – |
|
131
Shake Shack
SHAK
$3.06B
| $458K | 0.01% |
+11,000
| New | +$457K |
|
132
Booking.com
BKNG
$158B
| $437K | 0.01% |
5,250
+250
| +5% | +$19.7K |
|
133
HEICO Corp
HEI
$49.6B
| $407K | 0.01% |
5,859
-1,465
| -20% | -$95.8K |
|
134
Merck
MRK
$376B
| $305K | 0.01% |
5,869
| – | – |
|
135
Novartis
NVS
$302B
| $299K | 0.01% |
4,129
| – | – |
|
136
Liberty Latin America Class A
LILA
$1.66B
| $286K | 0.01% |
22,990
| – | – |
|
137
Illumina
ILMN
$33.1B
| $236K | ﹤0.01% |
1,028
| – | – |
|
138
Bunge Global
BG
$21.7B
| – | – |
-71,800
| Closed | -$4.82M |
|
|
139
PACCAR
PCAR
$69B
| – | – |
-177,450
| Closed | -$8.41M |
|
140
VF Corp
VFC
$5.65B
| – | – |
-32,710
| Closed | -$2.28M |
|
|
PDCO
141
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-168,000
| Closed | -$6.07M |
|
|
AGN
142
DELISTED
Allergan plc
AGN
| – | – |
-33,000
| Closed | -$5.4M |
|
|
COL
143
DELISTED
Rockwell Collins
COL
| – | – |
-37,000
| Closed | -$5.02M |
|
|
MON
144
DELISTED
Monsanto Co
MON
| – | – |
-396,700
| Closed | -$46.3M |
|
Similar funds
Tom Gayner's Q1 2018 Portfolio in Review
As of Q1 2018, Tom Gayner held 144 positions worth $5.26B, down 0.68% from $5.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Tom Gayner's Q1 2018 filing shows 6 new, 42 increased, 5 reduced and 7 closed positions. Its largest new stake was Progressive: 210,000 shares worth $12.8M. The largest sale was Monsanto Co, an estimated $46.3M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Tom Gayner's largest Q1 2018 buy was Progressive: 210,000 shares worth $12.8M.
- Tom Gayner added most to Starbucks in Q1 2018, an estimated $9.08M increase.
- Tom Gayner's biggest Q1 2018 reduction was Moody's, cutting an estimated $14.6M.
- Tom Gayner fully exited Monsanto Co in Q1 2018, selling an estimated $46.3M.
- Tom Gayner's ten largest holdings make up 42% of its $5.26B portfolio in Q1 2018.
- Tom Gayner opened 6 new positions and closed 7 in Q1 2018.
- Tom Gayner's portfolio value fell 0.68% quarter-over-quarter to $5.26B.
Based on Markel Group's 13F filing for Q1 2018, filed 27 Apr 2018.